| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-070276 |
| cik | 1262104 |
| name | MEI PHARMA, INC. |
| sic | 2834 |
| countryba | US |
| stprba | CA |
| cityba | SAN DIEGO |
| zipba | 92130 |
| bas1 | 11455 EL CAMINO REAL |
| bas2 | SUITE 250 |
| baph | 858-369-7100 |
| countryma | US |
| stprma | CA |
| cityma | SAN DIEGO |
| zipma | 92130 |
| mas1 | 11455 EL CAMINO REAL |
| mas2 | SUITE 250 |
| countryinc | US |
| stprinc | DE |
| ein | 510407811 |
| former | MARSHALL EDWARDS INC |
| changed | 20030902 |
| afs | 4-NON |
| wksi | 0 |
| fye | 0630 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q3 |
| filed | 20250513 |
| accepted | 2025-05-13 16:00:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | meip-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-070276 | 20250331 | Accrued Liabilities Current | 1061000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Additional Paid In Capital Common Stock | 421017000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 668000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 668000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2368000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20231231 | Common Stock Dividends Per Share Declared | 1.7500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Common Stock Dividends Per Share Declared | 1.7500 | USD | 3 | us-gaap/2024 | Dividends= O2024 Q2 Dividends; | ||
| 0000950170-25-070276 | 20250331 | Common Stock Shares Issued | 6663000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Common Stock Shares Outstanding | 6663000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Costs And Expenses | 2774000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Depreciation Depletion And Amortization | 368000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Earnings Per Share Diluted | -1.3700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Earnings Per Share Diluted | 5.4300 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Gain Loss On Sale Of Property Plant Equipment | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Increase Decrease In Accounts Payable Trade | -2991000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Increase Decrease In Accrued Liabilities | -4126000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -4144000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Investment Income Interest And Dividend | 836000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Net Cash Provided By Used In Investing Activities | 35150000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Net Income Loss | -9127000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20241231 | Net Income Loss | -2677000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Operating Income Loss | -9829000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Other Nonoperating Income Expense | -4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Payments To Acquire Property Plant And Equipment | 7000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 10000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Revenues | 64545000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Collaboration Agreements; | ||
| 0000950170-25-070276 | 20250331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; | ||
| 0000950170-25-070276 | 20250331 | Share Based Compensation | -159000.0000 | USD | 3 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-070276 | 20230630 | Stockholders Equity | 24624000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Stockholders Equity | -349623000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20240331 | Stockholders Equity | 51029000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20241231 | Stockholders Equity | 22098000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Share Based Compensation | 254000.0000 | USD | 3 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-070276 | 20241231 | Stockholders Equity | 421001000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6663000.0000 | shares | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Increase Decrease In Operating Lease Liability | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Accounts Payable Current | 3168000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Additional Paid In Capital Common Stock | 421239000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240930 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -135000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240630 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-070276 | 20240630 | Common Stock Shares Authorized | 226000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Common Stock Shares Authorized | 226000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Costs And Expenses | 9829000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Earnings Per Share Basic | -0.3900 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Financing Costs Included In Accounts Payable | 208000.0000 | USD | 3 | 0000950170-25-070276 | |||
| 0000950170-25-070276 | 20250331 | General And Administrative Expense | 10737000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Liabilities Current | 8355000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Liabilities Current | 1238000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240930 | Net Income Loss | -8007000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20241231 | Net Income Loss | -2677000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Net Income Loss | -13257000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Nonoperating Income Expense | 2662000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20231130 | Payments Of Dividends | 11700000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Proceeds From Sale Of Other Assets Investing Activities | 500000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20241231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Assets Current | 20779000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Cash And Cash Equivalents At Carrying Value | 3705000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Cash And Cash Equivalents At Carrying Value | 20472000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Common Stock Shares Issued | 6663000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Earnings Per Share Diluted | -0.3900 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Increase Decrease In Contract With Customer Liability | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Net Cash Provided By Used In Investing Activities | 29596000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Net Cash Provided By Used In Operating Activities | -18383000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Net Income Loss | -2573000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Other Nonoperating Income Expense | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Preferred Stock Shares Authorized | 100000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Prepaid Expense And Other Assets Current | 2424000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Profit Loss | 36184000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Research And Development Expense | 12617000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Research And Development Expense | 3840000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Retained Earnings Accumulated Deficit | -401476000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; | ||
| 0000950170-25-070276 | 20240331 | Revenues | 752000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; | ||
| 0000950170-25-070276 | 20240331 | Share Based Compensation | 668000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Share Based Compensation | 1881000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Share Based Compensation | 16000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Stockholders Equity | 81361000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Stockholders Equity | 430984000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20230930 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20231231 | Stockholders Equity | 420174000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20231231 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 6663000.0000 | shares | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 363000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 363000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20241231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -103000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20230630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 16906000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 16767000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-070276 | 20240331 | Costs And Expenses | 31775000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Gain Loss On Sale Of Other Assets | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Net Income Loss | 36184000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Operating Lease Right Of Use Asset | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Other Nonoperating Income Expense | -7000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Profit Loss | -13257000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Collaboration Agreements; | ||
| 0000950170-25-070276 | 20240331 | Revenues | 65297000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Collaboration Agreements; | ||
| 0000950170-25-070276 | 20250331 | Revenues | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Share Based Compensation | 1627000.0000 | USD | 3 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0000950170-25-070276 | 20250331 | Share Based Compensation | 16000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0000950170-25-070276 | 20230630 | Stockholders Equity | 430621000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240331 | Stockholders Equity | 420842000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240930 | Stockholders Equity | 421104000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240930 | Stockholders Equity | -396226000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6663000.0000 | shares | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Stockholders Equity | -369813000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6663000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6663000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Common Stock Shares Outstanding | 6663000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Depreciation Depletion And Amortization | 258000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Earnings Per Share Basic | -1.3700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Gain Loss On Sale Of Other Assets | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | General And Administrative Expense | 4609000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | General And Administrative Expense | 2405000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Increase Decrease In Accounts Payable Trade | -3166000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Liabilities | 1238000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Liabilities And Stockholders Equity | 41375000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Net Cash Provided By Used In Operating Activities | -32474000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Net Income Loss | -9127000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20240930 | Net Income Loss | -8007000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Net Income Loss | -2573000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20240331 | Operating Income Loss | 33522000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | 34640000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Research And Development Expense | 369000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Retained Earnings Accumulated Deficit | -388219000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Revenues | 9000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Timing Of Transfer Of Good Or Service= Transferred At Point In Time; | ||
| 0000950170-25-070276 | 20250331 | Revenues | 0.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Collaboration Agreements; | ||
| 0000950170-25-070276 | 20250331 | Revenues | 0.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; | ||
| 0000950170-25-070276 | 20240331 | Share Based Compensation | 474000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0000950170-25-070276 | 20250331 | Share Based Compensation | -63000.0000 | USD | 3 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0000950170-25-070276 | 20231231 | Stockholders Equity | 59488000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20240630 | Stockholders Equity | 421239000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240630 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20241231 | Stockholders Equity | -398903000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Stockholders Equity | 19541000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230630 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20231231 | Stockholders Equity | -360686000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20231231 | Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | 11660000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20231231 | Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | 11660000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20231231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 850000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 16000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -14538000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Earnings Per Share Basic | -1.9900 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Financing Costs Included In Accounts Payable | 0.0000 | USD | 3 | 0000950170-25-070276 | |||
| 0000950170-25-070276 | 20250331 | Gain Loss On Sale Of Other Assets | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Gain Loss On Sale Of Property Plant Equipment | -14000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -2117000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Increase Decrease In Unbilled Receivable | -85000.0000 | USD | 3 | 0000950170-25-070276 | |||
| 0000950170-25-070276 | 20240331 | Investment Income Interest And Dividend | 706000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Liabilities | 8355000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Net Cash Provided By Used In Financing Activities | -11660000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Net Income Loss | 56374000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Non Cash Lease Expense | 214000.0000 | USD | 3 | 0000950170-25-070276 | |||
| 0000950170-25-070276 | 20250331 | Nonoperating Income Expense | 201000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Operating Income Loss | -2774000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Operating Lease Right Of Use Asset | 214000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Payments Of Dividends | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Payments To Acquire Short Term Investments | 58232000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Payments To Acquire Short Term Investments | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Prepaid Expense And Other Assets Current | 307000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20241031 | Proceeds From Sale Of Other Assets Investing Activities | 500000.0000 | USD | 0 | us-gaap/2024 | Transaction Type= Asset Purchase Agreement; | ||
| 0000950170-25-070276 | 20240630 | Property Plant And Equipment Net | 392000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Property Plant And Equipment Net | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Research And Development Expense | 5220000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Share Based Compensation | 194000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-070276 | 20250331 | Share Based Compensation | -222000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Short Term Investments | 34640000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Stockholders Equity | -388219000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 6663000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6663000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Accounts Payable Current | 177000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20231231 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Assets Current | 40769000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Costs And Expenses | 14577000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Earnings Per Share Basic | 5.4300 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | General And Administrative Expense | 19158000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Increase Decrease In Accrued Liabilities | -7073000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Increase Decrease In Contract With Customer Liability | -64862000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Liabilities And Stockholders Equity | 20779000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20231231 | Net Income Loss | -11063000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Operating Income Loss | -14577000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Other Nonoperating Income Expense | -16000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Preferred Stock Shares Authorized | 100000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Proceeds From Sale Of Other Assets Investing Activities | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Proceeds From Sale Of Property Plant And Equipment | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Revenues | 743000.0000 | USD | 3 | us-gaap/2024 | Concentration Risk By Benchmark= Revenue From Contract With Customer; Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
| 0000950170-25-070276 | 20250331 | Short Term Investments | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230630 | Stockholders Equity | -405997000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Stockholders Equity | 421017000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-070276 | 20250331 | Stockholders Equity | -401476000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6663000.0000 | shares | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Nonoperating Income Expense | 1320000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Payments Of Dividends | 11660000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Payments To Acquire Property Plant And Equipment | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240930 | Stockholders Equity | 24878000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | 87835000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-070276 | 20240630 | Accrued Liabilities Current | 5187000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Stockholders Equity | 33020000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240930 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -135000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 16000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Assets | 41375000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Assets | 20779000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 3705000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 20472000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Earnings Per Share Diluted | -1.9900 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Gain Loss On Sale Of Other Assets | 500000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Increase Decrease In Operating Lease Liability | -1061000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Increase Decrease In Unbilled Receivable | 0.0000 | USD | 3 | 0000950170-25-070276 | |||
| 0000950170-25-070276 | 20240331 | Investment Income Interest And Dividend | 2669000.0000 | USD | 3 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20250331 | Investment Income Interest And Dividend | 202000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20230930 | Net Income Loss | 56374000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-070276 | 20231231 | Net Income Loss | -11063000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240331 | Non Cash Lease Expense | 1136000.0000 | USD | 3 | 0000950170-25-070276 | |||
| 0000950170-25-070276 | 20240331 | Nonoperating Income Expense | 702000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-070276 | 20240930 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-070276 | 20241231 | Stockholders Equity | 6663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Increase Decrease In Accounts Payable Trade | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Maturities, Prepayments and Calls of Short-Term Investments | The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Investment Income Interest And Dividend | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest and Dividend | Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Payments Of Dividends | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Dividends | Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Common Stock Dividends Per Share Declared | us-gaap/2024 | 0 | 0 | perShare | D | Common Stock, Dividends, Per Share, Declared | Aggregate dividends declared during the period for each share of common stock outstanding. | |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Increase Decrease In Unbilled Receivable | 0000950170-25-070276 | 1 | 0 | monetary | D | C | Increase Decrease In Unbilled Receivable | Increase Decrease In Unbilled Receivable |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Non Cash Lease Expense | 0000950170-25-070276 | 1 | 0 | monetary | D | D | Non Cash Lease Expense | Non cash lease expense. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Financing Costs Included In Accounts Payable | 0000950170-25-070276 | 1 | 0 | monetary | D | C | Financing Costs Included in Accounts Payable | Financing costs included in accounts payable. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Sale Of Other Assets Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Other Assets, Investing Activities | Amount of cash inflow from the sale of other assets recognized in investing activities. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Gain Loss On Sale Of Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Other Assets | Amount of gain (loss) on sale or disposal of other assets. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Payments To Acquire Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Short-Term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-070276 | 7 | 19 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liability | 0 |
| 0000950170-25-070276 | 7 | 20 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-070276 | 2 | 7 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-070276 | 2 | 8 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
| 0000950170-25-070276 | 2 | 9 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-070276 | 2 | 10 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-070276 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset | 0 |
| 0000950170-25-070276 | 2 | 12 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-070276 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-070276 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-070276 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued liabilities | 0 |
| 0000950170-25-070276 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-070276 | 2 | 19 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-070276 | 2 | 20 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 6) | 0 |
| 0000950170-25-070276 | 2 | 22 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.01 par value; 100 shares authorized; none outstanding | 0 |
| 0000950170-25-070276 | 2 | 23 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.00000002 par value; 226,000 shares authorized; 6,663 shares issued and outstanding at March 31, 2025 and June 30, 2024. | 0 |
| 0000950170-25-070276 | 2 | 24 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-070276 | 2 | 25 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-070276 | 2 | 26 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-070276 | 2 | 27 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-070276 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0000950170-25-070276 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0000950170-25-070276 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0000950170-25-070276 | 3 | 6 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-070276 | 3 | 7 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-070276 | 3 | 8 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-070276 | 3 | 9 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0000950170-25-070276 | 4 | 9 | IS | 0 | H | Revenues | us-gaap/2024 | Revenues | 0 |
| 0000950170-25-070276 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-070276 | 4 | 12 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-070276 | 4 | 13 | IS | 0 | H | Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-070276 | 4 | 14 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | (Loss) income from operations | 0 |
| 0000950170-25-070276 | 4 | 16 | IS | 0 | H | Investment Income Interest And Dividend | us-gaap/2024 | Interest and dividend income | 0 |
| 0000950170-25-070276 | 4 | 17 | IS | 0 | H | Gain Loss On Sale Of Other Assets | us-gaap/2024 | Gain on disposition of a non-financial asset | 0 |
| 0000950170-25-070276 | 4 | 18 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other expense, net | 0 |
| 0000950170-25-070276 | 4 | 19 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income, net | 0 |
| 0000950170-25-070276 | 4 | 20 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net (loss) income | 0 |
| 0000950170-25-070276 | 4 | 22 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-070276 | 4 | 23 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-070276 | 4 | 25 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
| 0000950170-25-070276 | 4 | 26 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
| 0000950170-25-070276 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-070276 | 5 | 13 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-070276 | 5 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | us-gaap/2024 | Cash dividends declared | 1 |
| 0000950170-25-070276 | 5 | 15 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based compensation expense | 0 |
| 0000950170-25-070276 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-070276 | 6 | 1 | EQ | 1 | H | Common Stock Dividends Per Share Declared | us-gaap/2024 | Cash dividends declared, per share | 0 |
| 0000950170-25-070276 | 7 | 6 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net (loss) income | 0 |
| 0000950170-25-070276 | 7 | 8 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0000950170-25-070276 | 7 | 9 | CF | 0 | H | Non Cash Lease Expense | 0000950170-25-070276 | Noncash lease expense | 0 |
| 0000950170-25-070276 | 7 | 10 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation expense | 0 |
| 0000950170-25-070276 | 7 | 11 | CF | 0 | H | Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | Loss on disposal of property and equipment | 1 |
| 0000950170-25-070276 | 7 | 12 | CF | 0 | H | Gain Loss On Sale Of Other Assets | us-gaap/2024 | Gain on disposition of a non-financial asset | 1 |
| 0000950170-25-070276 | 7 | 14 | CF | 0 | H | Increase Decrease In Unbilled Receivable | 0000950170-25-070276 | Unbilled receivables | 1 |
| 0000950170-25-070276 | 7 | 15 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0000950170-25-070276 | 7 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable Trade | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-070276 | 7 | 17 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued liabilities | 0 |
| 0000950170-25-070276 | 7 | 18 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Deferred revenue | 0 |
| 0000950170-25-070276 | 7 | 22 | CF | 0 | H | Payments To Acquire Short Term Investments | us-gaap/2024 | Purchases of short-term investments | 1 |
| 0000950170-25-070276 | 7 | 23 | CF | 0 | H | Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | us-gaap/2024 | Proceeds from maturity of short-term investments | 0 |
| 0000950170-25-070276 | 7 | 24 | CF | 0 | H | Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | Proceeds from sale of property and equipment | 0 |
| 0000950170-25-070276 | 7 | 25 | CF | 0 | H | Proceeds From Sale Of Other Assets Investing Activities | us-gaap/2024 | Proceeds from the disposition of a non-financial asset | 0 |
| 0000950170-25-070276 | 7 | 26 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-070276 | 7 | 27 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0000950170-25-070276 | 7 | 29 | CF | 0 | H | Payments Of Dividends | us-gaap/2024 | Payment of cash dividend | 1 |
| 0000950170-25-070276 | 7 | 30 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash used in financing activities | 0 |
| 0000950170-25-070276 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0000950170-25-070276 | 7 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at beginning of the period | 0 |
| 0000950170-25-070276 | 7 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at end of the period | 0 |
| 0000950170-25-070276 | 7 | 35 | CF | 0 | H | Financing Costs Included In Accounts Payable | 0000950170-25-070276 | Financing costs included in accounts payable | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |